Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection

Berson, 2001, Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation, Journal of Hepatology, 34, 261, 10.1016/S0168-8278(00)00050-7 Berson, 2001, Hepatitis after intravenous buprenorphine misuse in heroin addicts, Journal of Hepatology, 34, 346, 10.1016/S0168-8278(00)00049-0 Bruce, 2007, Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases, American Journal of Drug & Alcohol Abuse, 33, 869, 10.1080/00952990701653875 Cicconi, 2007, Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?, AIDS, 21, 599, 10.1097/QAD.0b013e328013db9c Edelman, 2013, The next therapeutic challenge in HIV: Polypharmacy, Drugs & Aging, 30, 613, 10.1007/s40266-013-0093-9 Fiellin, 2006, Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence, New England Journal of Medicine, 355, 365, 10.1056/NEJMoa055255 Fiellin, 2011, Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone, JAIDS Journal of Acquired Immune Deficiency Syndromes, 56, S33, 10.1097/QAI.0b013e3182097537 Fultz, 2006, Development and verification of a "virtual" cohort using the national VA health information system, Medical Care, 44, S25, 10.1097/01.mlr.0000223670.00890.74 Gowing, 2009, Buprenorphine for the management of opioid withdrawal, Cochrane Database of Systematic Reviews, 3, CD002025 Gowing, 2011, Oral substitution treatment of injecting opioid users for prevention of HIV infection, Cochrane Database of Systematic Reviews, 8, CD004145 Herve, 2004, Acute hepatitis due to buprenorphine administration, European Journal of Gastroenterology & Hepatology, 16, 1033, 10.1097/00042737-200410000-00013 Lange, 1990, Safety and side-effects of buprenorphine in the clinical management of heroin addiction, Drug & Alcohol Dependence, 26, 19, 10.1016/0376-8716(90)90078-S Lo Re, 2013, Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's mini-sentinel distributed database, Pharmacoepidemiology & Drug Safety, 22, 861, 10.1002/pds.3470 Masson, 2014, Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals, American Journal on Addictions, 23, 34, 10.1111/j.1521-0391.2013.12052.x McNicholas, 2012, Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication, Addiction, 107, 91, 10.1111/j.1360-0443.2012.04043.x Petry, 2000, Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine, The American Journal on Addictions, 9, 265, 10.1080/10550490050148099 Saxon, 2013, Buprenorphine/naloxone and methadone effects on laboratory indices of liver health: A randomized trial, Drug & Alcohol Dependence, 128, 71, 10.1016/j.drugalcdep.2012.08.002 Soyka, 2014, Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study, The American Journal on Addictions, 23, 563, 10.1111/j.1521-0391.2014.12131.x Sullivan, 2006, A trial of integrated buprenorphine/naloxone and HIV clinical care, Clinical Infectious Diseases, 43, S184, 10.1086/508182 Sullivan, 2006, Training HIV physicians to prescribe buprenorphine for opioid dependence, Substance Abuse, 27, 13, 10.1300/J465v27n03_03 Tetrault, 2012, Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients, Journal of Substance Abuse Treatment, 43, 433, 10.1016/j.jsat.2012.07.011 Upadhyay, 2010, Buprenorphine-induced elevated liver enzymes in an adolescent patient, Journal of Child & Adolescent Psychopharmacology, 20, 545, 10.1089/cap.2009.0093 Vergara-Rodriguez, 2011, Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients, Journal of Acquired Immune Deficiency Syndromes: JAIDS, 56, S62, 10.1097/QAI.0b013e31820a820f Weiss, 2011, Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial, Archives of General Psychiatry, 68, 1238, 10.1001/archgenpsychiatry.2011.121 Zuin, 2009, Acute liver and renal failure during treatment with buprenorphine at therapeutic dose, Digestive & Liver Disease, 41, e8, 10.1016/j.dld.2007.12.014